CD14 and COVID-19: revealed the establishment of trained immunity in COVID-19 convalescent individuals via the single-cell epigenomic landscape of peripheral immune cells, showing that trained and activated states of CD14+ and CD16+ monocytes were dominantly enriched in individuals recovering from COVID-19 (You et al., 2021).